Publications. Advances in Therapy Matthijs Versteegh 7/25/23 Advances in Therapy Matthijs Versteegh 7/25/23 Societal Utilities for Cognitive Impairment in Schizophrenia: Developing a Preference-Based Scoring Algorithm Based on the Schizophrenia Cognition Rating Scale Read More Value in Health Matthijs Versteegh 7/7/22 Value in Health Matthijs Versteegh 7/7/22 Estimating Quality of Life Decrements in Oncology Using Time to Death Read More Health Economics Matthijs Versteegh 4/26/22 Health Economics Matthijs Versteegh 4/26/22 Correcting for discounting and loss aversion in composite time trade-off Read More quality of life, Value in Health Matthijs Versteegh 10/25/21 quality of life, Value in Health Matthijs Versteegh 10/25/21 Performance of the EQ-5D-5L Plus Respiratory Bolt-On in the Birmingham Chronic Obstructive Pulmonary Disease Cohort Study Read More quality of life, The Lancet: Regional Health Europe Matthijs Versteegh 7/19/21 quality of life, The Lancet: Regional Health Europe Matthijs Versteegh 7/19/21 Quality of life among people living with HIV in England and the Netherlands: a population-based study Read More quality of life, Quality of Life Research Matthijs Versteegh 7/9/21 quality of life, Quality of Life Research Matthijs Versteegh 7/9/21 The Mental Health Quality of Life Questionnaire (MHQoL): development and first psychometric evaluation of a new measure to assess quality of life in people with mental health problems Read More epilepsy, quality of life, Value in Health Matthijs Versteegh 7/2/21 epilepsy, quality of life, Value in Health Matthijs Versteegh 7/2/21 Good Days and Bad Days: Measuring Health-Related Quality of Life in People With Epilepsy Read More quality of life, Health & Quality of Life Outcomes Matthijs Versteegh 7/20/20 quality of life, Health & Quality of Life Outcomes Matthijs Versteegh 7/20/20 Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model Read More multiple sclerosis, Medical Decision Making Matthijs Versteegh 2/17/20 multiple sclerosis, Medical Decision Making Matthijs Versteegh 2/17/20 Summarizing patient preferences for the competitive landscape of multiple sclerosis treatment options Read More quality of life, Social Science & Medicine Matthijs Versteegh 1/15/19 quality of life, Social Science & Medicine Matthijs Versteegh 1/15/19 Can time heal all wounds? An empirical assessment of adaptation to functional limitations in an older population Read More quality of life, informal care, Pharmacoeconomics Matthijs Versteegh 8/28/18 quality of life, informal care, Pharmacoeconomics Matthijs Versteegh 8/28/18 Estimating Informal Caregiving Time from Patient EQ-5D Data: The Informal CARE Effect (iCARE) Tool Read More quality of life, oncology, Quality of Life Research Matthijs Versteegh 9/15/17 quality of life, oncology, Quality of Life Research Matthijs Versteegh 9/15/17 Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma Read More quality of life, Health Economics Matthijs Versteegh 10/27/16 quality of life, Health Economics Matthijs Versteegh 10/27/16 Are Health State Valuations from the General Public Biased? A Test of Health State Reference Dependency Using Self-assessed Health and an Efficient Discrete Choice Experiment Read More quality of life, methods, Social Science & Medicine Matthijs Versteegh 8/5/16 quality of life, methods, Social Science & Medicine Matthijs Versteegh 8/5/16 Patient and general public preferences for health states: A call to reconsider current guidelines Read More quality of life, Value in Health Matthijs Versteegh 3/30/16 quality of life, Value in Health Matthijs Versteegh 3/30/16 Dutch Tariff for the Five-Level Version of EQ-5D Read More quality of life, methods, European Journal of Health Economics Matthijs Versteegh 7/31/13 quality of life, methods, European Journal of Health Economics Matthijs Versteegh 7/31/13 Introducing the composite time trade-off: a test of feasibility and face validity Read More quality of life, methods, European Journal of Health Economics Matthijs Versteegh 7/31/13 quality of life, methods, European Journal of Health Economics Matthijs Versteegh 7/31/13 Time trade-off: one methodology, different methods Read More quality of life, methods, European Journal of Health Economics Matthijs Versteegh 7/31/13 quality of life, methods, European Journal of Health Economics Matthijs Versteegh 7/31/13 Time to tweak the TTO: results from a comparison of alternative specifications of the TTO Read More quality of life, methods, Health Economics Matthijs Versteegh 12/11/12 quality of life, methods, Health Economics Matthijs Versteegh 12/11/12 WOULD YOU RATHER BE ILL NOW, OR LATER? Read More quality of life, methods, Health & Quality of Life Outcomes, Health Economics Matthijs Versteegh 3/6/12 quality of life, methods, Health & Quality of Life Outcomes, Health Economics Matthijs Versteegh 3/6/12 LEAD TIME TTO: LEADING TO BETTER HEALTH STATE VALUATIONS? Read More Older Posts
Advances in Therapy Matthijs Versteegh 7/25/23 Advances in Therapy Matthijs Versteegh 7/25/23 Societal Utilities for Cognitive Impairment in Schizophrenia: Developing a Preference-Based Scoring Algorithm Based on the Schizophrenia Cognition Rating Scale Read More
Value in Health Matthijs Versteegh 7/7/22 Value in Health Matthijs Versteegh 7/7/22 Estimating Quality of Life Decrements in Oncology Using Time to Death Read More
Health Economics Matthijs Versteegh 4/26/22 Health Economics Matthijs Versteegh 4/26/22 Correcting for discounting and loss aversion in composite time trade-off Read More
quality of life, Value in Health Matthijs Versteegh 10/25/21 quality of life, Value in Health Matthijs Versteegh 10/25/21 Performance of the EQ-5D-5L Plus Respiratory Bolt-On in the Birmingham Chronic Obstructive Pulmonary Disease Cohort Study Read More
quality of life, The Lancet: Regional Health Europe Matthijs Versteegh 7/19/21 quality of life, The Lancet: Regional Health Europe Matthijs Versteegh 7/19/21 Quality of life among people living with HIV in England and the Netherlands: a population-based study Read More
quality of life, Quality of Life Research Matthijs Versteegh 7/9/21 quality of life, Quality of Life Research Matthijs Versteegh 7/9/21 The Mental Health Quality of Life Questionnaire (MHQoL): development and first psychometric evaluation of a new measure to assess quality of life in people with mental health problems Read More
epilepsy, quality of life, Value in Health Matthijs Versteegh 7/2/21 epilepsy, quality of life, Value in Health Matthijs Versteegh 7/2/21 Good Days and Bad Days: Measuring Health-Related Quality of Life in People With Epilepsy Read More
quality of life, Health & Quality of Life Outcomes Matthijs Versteegh 7/20/20 quality of life, Health & Quality of Life Outcomes Matthijs Versteegh 7/20/20 Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model Read More
multiple sclerosis, Medical Decision Making Matthijs Versteegh 2/17/20 multiple sclerosis, Medical Decision Making Matthijs Versteegh 2/17/20 Summarizing patient preferences for the competitive landscape of multiple sclerosis treatment options Read More
quality of life, Social Science & Medicine Matthijs Versteegh 1/15/19 quality of life, Social Science & Medicine Matthijs Versteegh 1/15/19 Can time heal all wounds? An empirical assessment of adaptation to functional limitations in an older population Read More
quality of life, informal care, Pharmacoeconomics Matthijs Versteegh 8/28/18 quality of life, informal care, Pharmacoeconomics Matthijs Versteegh 8/28/18 Estimating Informal Caregiving Time from Patient EQ-5D Data: The Informal CARE Effect (iCARE) Tool Read More
quality of life, oncology, Quality of Life Research Matthijs Versteegh 9/15/17 quality of life, oncology, Quality of Life Research Matthijs Versteegh 9/15/17 Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma Read More
quality of life, Health Economics Matthijs Versteegh 10/27/16 quality of life, Health Economics Matthijs Versteegh 10/27/16 Are Health State Valuations from the General Public Biased? A Test of Health State Reference Dependency Using Self-assessed Health and an Efficient Discrete Choice Experiment Read More
quality of life, methods, Social Science & Medicine Matthijs Versteegh 8/5/16 quality of life, methods, Social Science & Medicine Matthijs Versteegh 8/5/16 Patient and general public preferences for health states: A call to reconsider current guidelines Read More
quality of life, Value in Health Matthijs Versteegh 3/30/16 quality of life, Value in Health Matthijs Versteegh 3/30/16 Dutch Tariff for the Five-Level Version of EQ-5D Read More
quality of life, methods, European Journal of Health Economics Matthijs Versteegh 7/31/13 quality of life, methods, European Journal of Health Economics Matthijs Versteegh 7/31/13 Introducing the composite time trade-off: a test of feasibility and face validity Read More
quality of life, methods, European Journal of Health Economics Matthijs Versteegh 7/31/13 quality of life, methods, European Journal of Health Economics Matthijs Versteegh 7/31/13 Time trade-off: one methodology, different methods Read More
quality of life, methods, European Journal of Health Economics Matthijs Versteegh 7/31/13 quality of life, methods, European Journal of Health Economics Matthijs Versteegh 7/31/13 Time to tweak the TTO: results from a comparison of alternative specifications of the TTO Read More
quality of life, methods, Health Economics Matthijs Versteegh 12/11/12 quality of life, methods, Health Economics Matthijs Versteegh 12/11/12 WOULD YOU RATHER BE ILL NOW, OR LATER? Read More
quality of life, methods, Health & Quality of Life Outcomes, Health Economics Matthijs Versteegh 3/6/12 quality of life, methods, Health & Quality of Life Outcomes, Health Economics Matthijs Versteegh 3/6/12 LEAD TIME TTO: LEADING TO BETTER HEALTH STATE VALUATIONS? Read More